Comprehensive study of ibuprofen and its metabolites in activated sludge batch experiments and aquatic environment

Science of the Total Environment

Volumn 438, Issue , 2012, Pages 404-413

  Ferrando Climent, Laura ^a   Collado, Neus ^a   Buttiglieri, Gianluigi ^a   Gros, Meritxell ^a   Rodriguez Roda, Ignasi ^a   Rodriguez Mozaz, Sara ^a   Barceló, Damià ^a,b  

^a UNIVERSITY OF GIRONA   (Spain)

^b INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Biodegradation pathways; Ibuprofen; Metabolites; Transformation products; Wastewater treatment plant

Indexed keywords

ACTIVATED SLUDGE; AQUATIC ENVIRONMENTS; BATCH EXPERIMENTS; BIODEGRADATION EXPERIMENTS; BIODEGRADATION PATHWAYS; BIODEGRADATION PROCESS; BIOTRANSFORMATION PRODUCT; COMPREHENSIVE STUDIES; HUMAN METABOLISMS; HYDROXYLATED METABOLITES; IBUPROFEN; IBUPROFEN METABOLITES; NATURAL WATER SAMPLES; NATURAL WATERS; REMOVAL RATE; TRANSFORMATION PRODUCTS; WASTEWATER SAMPLES; WASTEWATER TREATMENT PLANTS; WORKING CONDITIONS;

BIODEGRADATION; CARBOXYLIC ACIDS; EFFLUENTS; EXPERIMENTS; HYDROXYLATION; METABOLISM; METABOLITES; MICROBIOLOGY; SEDIMENTS; SEWAGE; SEWAGE PUMPING PLANTS; TOXICITY; WATER TREATMENT PLANTS;

BIOMOLECULES;

1 HYDROXYIBUPROFEN; 2 HYDROXYIBUPROFEN; DRUG METABOLITE; IBUPROFEN; IBUPROFEN CARBOXYLIC ACID; RIVER WATER; UNCLASSIFIED DRUG; WATER;

ACTIVATED SLUDGE; AQUATIC ENVIRONMENT; BIODEGRADATION; DRUG; METABOLITE; QUANTITATIVE ANALYSIS; WASTEWATER;

ACTIVATED SLUDGE; AQUATIC ENVIRONMENT; ARTICLE; BIODEGRADATION; BIOTRANSFORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG STRUCTURE; ENVIRONMENTAL MONITORING; HYDROXYLATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEWAGE; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT; WATER SAMPLING;

BIODEGRADATION, ENVIRONMENTAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESIDUES; FRESH WATER; IBUPROFEN; MOLECULAR STRUCTURE; RIVERS; SEWAGE; TANDEM MASS SPECTROMETRY; WASTE DISPOSAL, FLUID; WASTE WATER;

EID: 84866720996     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.08.073     Document Type: Article

References (36)

1. (2002/657/EC) CD Commission Decision (2002/657/EC) of 12 August 2002 Implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Official Journal of the European Communities L221, Brussels, Belgium 2002, 8-36.
2. Bastos Borgues K., Rodrigo Moraes de Oliveira A., Barth T., Polizel Jabor V.A., Tallarico Pupo M., Bonato P.S. LC-MS-MS determination of ibuprofen, 2-hydroxyibuprofen enantiomers, and carboxyibuprofen stereoisomers for application in biotransformation studies employing endophytic fungi. Anal Bioanal Chem 2011, 399:915-925.
3. Boxall ABA, Rudd MA, Brooks BW, Caldwell DJ, Choi K, Hickmann S, et al. Pharmaceuticals and Personal Care Products in the Environment: What are the Big Questions?. Environ Health Perspect 2012, 120:1221-1229.
4. Buser H.R., Poiger T., Muller M.D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 1999, 33:2529-2535.
5. Caliman F.A., Gavrilescu M. Pharmaceutical, personal care products and endocrine disrupting agents in the environment-review. Clean 2009, 37:277-303.
6. Caviglioli G., Valeria P., Brunella P., Sergio C., Attilia A., Gaetano B. Identification of degradation products of Ibuprofen arising from oxidative and thermal treatments. J Pharm Biomed Anal 2002, 30:499-509.
7. Clayton E., Taylor S., Wright B., Wilson I.D. The application of high performance liquid chromatography, coupled to nuclear magnetic resonance spectroscopy and mass spectrometry (HPLC-NMR-MS), to the characterisation of ibuprofen metabolites from human urine. Chromatographia 1998, 47:264-270.
8. de Oliveira A.R.M., de Santana F.J.M., Bonato P.S. Stereoselective determination of the major ibuprofen metabolites in human urine by off-line coupling solid-phase microextraction and high-performance liquid chromatography. Anal Chim Acta 2005, 538:25-34.
9. Djukovic D., Appiah-Amponsah E., Shanaiah N., Gowda G.A.N., Henry I., Everly M., et al. Ibuprofen metabolite profiling using a combination of SPE/column-trapping and HPLC-micro-coil NMR. J Pharm Biomed Anal 2008, 47:328-334.
10. Farré M., Perez S., Kantiani L., Barcelo D. Fate and toxicity of emerging pollutants, their metabolites and transformation products in aquatic environment. Trac-Trends Anal Chem 2008, 27:991-1007.
11. Gagnon C., Lajeunesse A. Persistence and fate of highly soluble pharmaceutical products in various types of municipal wastewater treatment plants. Waste management and the environment Iv 2008, 109:799-807.
12. Garcia-Galan M.J., Villagrasa M., Diaz-Cruz M.S., Barcelo D. LC-QqLIT MS analysis of nine sulfonamides and one of their acetylated metabolites in the Llobregat River basin. Quantitative determination and qualitative evaluation by IDA experiments. Anal Bioanal Chem 2010, 397:1325-1334.
13. Gros M., Petrovic M., Barceló D. Development of a multi-residue analytical methodology based on liquid chromatographyc tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70:678-690.
14. Gros M., Petrovic M., Barcelo D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 2009, 81:898-912.
15. Gros M., Rodriguez-Mozaz S., Barcelo D. Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J Chromatogr A 2012, 1248:104-121.
16. Jelic A., Petrovic M., Barcelo D. Multi-residue method for trace level determination of pharmaceuticals in solid samples using pressurized liquid extraction followed by liquid chromatography/quadrupole-linear ion trap mass spectrometry. Talanta 2009, 80:363-371.
17. Johnson C.H., Wilson I.D., Harding J.R., Stachulski A.V., Iddon L., Nicholson J.K., et al. NMR spectroscopic studies on the in vitro acyl glucuronide migration kinetics of lbuprofen ((+/-)-(R, S)-2-(4-Isobutylphenyl) propanoic acid), its metabolites, and analogues. Anal Chem 2007, 79:8720-8727.
18. Langin A., Schuster A., Kummerer K. Chemicals in the environment - the need for a clear nomenclature: parent compounds, metabolites, transformation products and their elimination. Clean-Soil Air Water 2008, 36:349-350.
19. Lishman L., Smyth S.A., Sarafin K., Kleywegt S., Toito J., Peart T., et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci Total Environ 2006, 367:544-558.
20. Marco-Urrea E., Pérez-Trujillo M., Vicent T., Caminal G. Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor. Chemosphere 2009, 74:765-772.
21. Matamoros V.C., Hijosa M.A., Bayona J.M. Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen. Chemosphere 2009, 75:200-205.
22. Mills R.F.N., Adams S.S., Cliffe E.E., Dickinso W., Nicholso J.S. Metabolism of ibuprofen. Xenobiotica 1973, 3:589-598.
23. Onesios K.M., Yu J.T., Bouwer E.J. Biodegradation and removal of pharmaceutical and personal care products in treatment systems: a review. Biodegradation 2009, 20:441-466.
24. Paxeus N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci Technol 2004, 50:253-260.
25. Pomati F., Castiglioni S., Zuccato E., Fanelli R., Vigetti D., Rossetti C., et al. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ Sci Technol 2006, 40:2442-2447.
26. Quintana J.B., Weiss S., Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by membrane reactor. Water Res 2005, 39:2654-2664.
27. Santos L.H.M.L.M., Araújo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C.B.S.M. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 2010, 175:45-95.
28. Schnell S., Kawano A., Porte C., Lee L.E.J., Bols N.C. Effects of Ibuprofen on the viability and proliferation of rainbow trout liver cell lines and potential problems and interactions in effects assessment. Environ Toxicol 2009, 24:157-165.
29. SNS Drug market National Health System. General Council of Official Colleges of Pharmacists of Spain 2008.
30. Teijon G., Candela L., Tamoh K., Molina-Diaz A., Fernandez-Alba A. Occurrence of emerging contaminants, priority substances (2008/105/CE) and heavy metals in treated wastewater and groundwater at Depurbaix facility (Barcelona, Spain). Sci Total Environ 2010, 408:3584-3595.
31. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32:3245-3260.
32. Ternes T.A. Analytical methods for the determination of pharmaceuticals in aqueous environmental samples. Trac-Trends Anal Chem 2001, 20:419-434.
33. Weigel S., Kallenborn R., Hühnerfuss H. Simultaneous solid-phase extraction of acidic, neutral and basic pharmaceuticals from aqueous samples at ambient (neutral) pH and their determination by gas chromatographyc mass spectrometry. J Chromatogr A 2003, 1023:183-195.
34. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H., Hühnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsã̧/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583-592.
35. Winkler M., Lawrence J.R., Neu T.R. Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Res 2001, 35:3197-3205.
36. Zwiener C., Seeger S., Glauner T., Frimmel F.H. Metabolites from biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Anal Bioanal Chem 2002, 372:569-575.